The Preferred Reporting Items for Systematic Review and Meta-Analysis of Diagnostic Test Accuracy studies (PRISMA-DTA): Explanation, Elaboration and Checklist.

Jean-Paul Salameh; Patrick M. Bossuyt; Trevor A McGrath; Brett D Thombs; Christopher J Hyde; Petra Macaskill; Jon Deeks; Mariska M G Leeflang; Daniël A. Korevaar; Penny Whiting; Yemisi Takwoingi; Johannes B. Reitsma; Jérémie F. Cohen; Robert A  Frank; Harriet A Hunt; Lotty Hooft; Anne W S Rutjes; Brian H Willis; Constantine A. Gatsonis; Brooke  Levis; David Moher; Matthew DF  McInnes

The Preferred Reporting Items for Systematic Review and Meta-Analysis of Diagnostic Test Accuracy studies (PRISMA-DTA): Explanation, Elaboration and Checklist.

Jean-Paul Salameh, Patrick M. Bossuyt, Trevor A McGrath, Brett D Thombs, Christopher J Hyde, Petra Macaskill, Jon Deeks, Mariska M G Leeflang, Daniël A. Korevaar, Penny Whiting, Yemisi Takwoingi, Johannes B. Reitsma, Jérémie F. Cohen, Robert A Frank, Harriet A Hunt, Lotty Hooft, Anne W S Rutjes, Brian H Willis, Constantine A. Gatsonis, Brooke LevisDavid Moher, Matthew DF McInnes

Applied Health Research

Research output: Contribution to journal › Article › peer-review

Abstract

Systematic reviews of diagnostic test accuracy (DTA) studies are fundamental to the decision-making process in evidence-based medicine. Although such studies are regarded as high-level evidence, these reviews are not always reported completely and transparently. Suboptimal reporting of DTA systematic reviews compromises their validity and generalizability, and subsequently their value to key stakeholders. PRISMA-DTA, an extension of the PRISMA statement, was recently developed to improve the quality of reporting of DTA systematic
reviews. The PRISMA-DTA statement consists of 27 items, of which 8 are unmodified from the original PRISMA statement. This document provides an explanation for the 19 new and modified items, along with their meaning and rationale. Examples of complete reporting are used for each item to illustrate best practices. The PRISMA-DTA statement, this explanation and elaboration document, and the associated web site (http://www.prismastatement.org/Extensions/DTA) provide resources to support the complete and transparent reporting of DTA systematic reviews.

Original language	English
Journal	BMJ
Publication status	Accepted/In press - 20 May 2020

Cite this

Salameh, J-P., Bossuyt, P. M., McGrath, T. A., Thombs, B. D., Hyde, C. J., Macaskill, P., Deeks, J., Leeflang, M. M. G., Korevaar, D. A., Whiting, P., Takwoingi, Y., Reitsma, J. B., Cohen, J. F., Frank, R. A., Hunt, H. A., Hooft, L., Rutjes, A. W. S., Willis, B. H., Gatsonis, C. A., ... McInnes, M. DF. (Accepted/In press). The Preferred Reporting Items for Systematic Review and Meta-Analysis of Diagnostic Test Accuracy studies (PRISMA-DTA): Explanation, Elaboration and Checklist. BMJ.

@article{d479cb7202c34c7c85074a36095804c8,

title = "The Preferred Reporting Items for Systematic Review and Meta-Analysis of Diagnostic Test Accuracy studies (PRISMA-DTA): Explanation, Elaboration and Checklist.",

abstract = "Systematic reviews of diagnostic test accuracy (DTA) studies are fundamental to the decision-making process in evidence-based medicine. Although such studies are regarded as high-level evidence, these reviews are not always reported completely and transparently. Suboptimal reporting of DTA systematic reviews compromises their validity and generalizability, and subsequently their value to key stakeholders. PRISMA-DTA, an extension of the PRISMA statement, was recently developed to improve the quality of reporting of DTA systematicreviews. The PRISMA-DTA statement consists of 27 items, of which 8 are unmodified from the original PRISMA statement. This document provides an explanation for the 19 new and modified items, along with their meaning and rationale. Examples of complete reporting are used for each item to illustrate best practices. The PRISMA-DTA statement, this explanation and elaboration document, and the associated web site (http://www.prismastatement.org/Extensions/DTA) provide resources to support the complete and transparent reporting of DTA systematic reviews.",

author = "Jean-Paul Salameh and Bossuyt, {Patrick M.} and McGrath, {Trevor A} and Thombs, {Brett D} and Hyde, {Christopher J} and Petra Macaskill and Jon Deeks and Leeflang, {Mariska M G} and Korevaar, {Dani{\"e}l A.} and Penny Whiting and Yemisi Takwoingi and Reitsma, {Johannes B.} and Cohen, {J{\'e}r{\'e}mie F.} and Frank, {Robert A} and Hunt, {Harriet A} and Lotty Hooft and Rutjes, {Anne W S} and Willis, {Brian H} and Gatsonis, {Constantine A.} and Brooke Levis and David Moher and McInnes, {Matthew DF}",

year = "2020",

month = may,

day = "20",

language = "English",

journal = "BMJ",

issn = "0959-535X",

publisher = "BMJ Publishing Group",

}

Salameh, J-P, Bossuyt, PM, McGrath, TA, Thombs, BD, Hyde, CJ, Macaskill, P, Deeks, J, Leeflang, MMG, Korevaar, DA, Whiting, P, Takwoingi, Y, Reitsma, JB, Cohen, JF, Frank, RA, Hunt, HA, Hooft, L, Rutjes, AWS, Willis, BH, Gatsonis, CA, Levis, B, Moher, D & McInnes, MDF 2020, 'The Preferred Reporting Items for Systematic Review and Meta-Analysis of Diagnostic Test Accuracy studies (PRISMA-DTA): Explanation, Elaboration and Checklist.', BMJ.

TY - JOUR

T1 - The Preferred Reporting Items for Systematic Review and Meta-Analysis of Diagnostic Test Accuracy studies (PRISMA-DTA): Explanation, Elaboration and Checklist.

AU - Salameh, Jean-Paul

AU - Bossuyt, Patrick M.

AU - McGrath, Trevor A

AU - Thombs, Brett D

AU - Hyde, Christopher J

AU - Macaskill, Petra

AU - Deeks, Jon

AU - Leeflang, Mariska M G

AU - Korevaar, Daniël A.

AU - Whiting, Penny

AU - Takwoingi, Yemisi

AU - Reitsma, Johannes B.

AU - Cohen, Jérémie F.

AU - Frank, Robert A

AU - Hunt, Harriet A

AU - Hooft, Lotty

AU - Rutjes, Anne W S

AU - Willis, Brian H

AU - Gatsonis, Constantine A.

AU - Levis, Brooke

AU - Moher, David

AU - McInnes, Matthew DF

PY - 2020/5/20

Y1 - 2020/5/20

N2 - Systematic reviews of diagnostic test accuracy (DTA) studies are fundamental to the decision-making process in evidence-based medicine. Although such studies are regarded as high-level evidence, these reviews are not always reported completely and transparently. Suboptimal reporting of DTA systematic reviews compromises their validity and generalizability, and subsequently their value to key stakeholders. PRISMA-DTA, an extension of the PRISMA statement, was recently developed to improve the quality of reporting of DTA systematicreviews. The PRISMA-DTA statement consists of 27 items, of which 8 are unmodified from the original PRISMA statement. This document provides an explanation for the 19 new and modified items, along with their meaning and rationale. Examples of complete reporting are used for each item to illustrate best practices. The PRISMA-DTA statement, this explanation and elaboration document, and the associated web site (http://www.prismastatement.org/Extensions/DTA) provide resources to support the complete and transparent reporting of DTA systematic reviews.

AB - Systematic reviews of diagnostic test accuracy (DTA) studies are fundamental to the decision-making process in evidence-based medicine. Although such studies are regarded as high-level evidence, these reviews are not always reported completely and transparently. Suboptimal reporting of DTA systematic reviews compromises their validity and generalizability, and subsequently their value to key stakeholders. PRISMA-DTA, an extension of the PRISMA statement, was recently developed to improve the quality of reporting of DTA systematicreviews. The PRISMA-DTA statement consists of 27 items, of which 8 are unmodified from the original PRISMA statement. This document provides an explanation for the 19 new and modified items, along with their meaning and rationale. Examples of complete reporting are used for each item to illustrate best practices. The PRISMA-DTA statement, this explanation and elaboration document, and the associated web site (http://www.prismastatement.org/Extensions/DTA) provide resources to support the complete and transparent reporting of DTA systematic reviews.

M3 - Article

SN - 0959-535X

JO - BMJ

JF - BMJ

ER -

The Preferred Reporting Items for Systematic Review and Meta-Analysis of Diagnostic Test Accuracy studies (PRISMA-DTA): Explanation, Elaboration and Checklist.

Abstract

Fingerprint

Cite this